245 related articles for article (PubMed ID: 30536305)
41. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
42. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
Yang G; Song R; Wang L; Wu X
Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
[TBL] [Abstract][Full Text] [Related]
43. Long Non-Coding RNA FOXD2-AS1 Serves as a Potential Prognostic Biomarker for Patients With Cancer: A Meta-Analysis and Database Testing.
Duan F; Li H; Liu W; Zhao J; Yang Z; Zhang J
Am J Med Sci; 2021 Aug; 362(2):173-181. PubMed ID: 34303519
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA MALAT1 is an independent prognostic factor of osteosarcoma.
Gao KT; Lian D
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
[TBL] [Abstract][Full Text] [Related]
45. Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; He QM; Huang BJ; Sun Y; Xie D; Zeng J; Wang HY; Ma J
Med Oncol; 2013 Mar; 30(1):360. PubMed ID: 23307239
[TBL] [Abstract][Full Text] [Related]
46. DDX11-AS1 contributes to osteosarcoma progression via stabilizing DDX11.
Zhang H; Lin J; Chen J; Gu W; Mao Y; Wang H; Zhang Y; Liu W
Life Sci; 2020 Aug; 254():117392. PubMed ID: 32014424
[TBL] [Abstract][Full Text] [Related]
47. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
48. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
[TBL] [Abstract][Full Text] [Related]
49. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
50. Prognostic and diagnostic significance of long non-coding RNA AGAP2-AS1 levels in patients with non-small cell lung cancer.
Fan KJ; Liu Y; Yang B; Tian XD; Li CR; Wang B
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2392-2396. PubMed ID: 28617550
[TBL] [Abstract][Full Text] [Related]
51. Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function.
Mi Z; Dong Y; Wang Z; Ye P
J Orthop Surg Res; 2021 Jul; 16(1):470. PubMed ID: 34321018
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
Li AH; Zhang HH
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
[TBL] [Abstract][Full Text] [Related]
53. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
Gong W; Tian M; Qiu H; Yang Z
Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
[TBL] [Abstract][Full Text] [Related]
54. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
Li RZ; Wang LM
World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
56. [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma].
Zhang JJ; Yang P; Shang XQ
Zhongguo Gu Shang; 2023 Jun; 36(6):559-64. PubMed ID: 37366099
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
[TBL] [Abstract][Full Text] [Related]
58. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.
Yang Y; Wang S; Li T
Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638
[TBL] [Abstract][Full Text] [Related]
59. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
60. Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.
Zhang CL; Zhu KP; Ma XL
Cancer Lett; 2017 Jun; 396():66-75. PubMed ID: 28323030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
